Cefotaxime Induced Staphylococcal Scalded Skin Syndrome: A Case Report

Published on:April 2021
Indian Journal of Pharmacy Practice, 2021; 14(2):151-153
Case Report | doi:10.5530/ijopp.14.2.29


Cefotaxime Induced Staphylococcal Scalded Skin Syndrome: A Case Report


Authors and affiliation (s):

Shirisha Jakkula1, Satish Chinnala2, Shravani Komuravelly1, Venkateshwarlu Eggadi1,*

1Department of Clinical Pharmacy and Pharm.D, Vaagdevi College of Pharmacy, Mahatma Gandhi Memorial Hospital, Warangal, Telangana, INDIA.

2Department of Clinical Pharmacy and Pharm.D, Vaagdevi Pharmacy College, Bollikunta, Warangal, Telangana, INDIA.

Abstract:

Staphylococcal Scalded Skin Syndrome (SSSS) is as well called as Ritter von Ritterschein disease, Lyell disease, Ritter disease and staphylococcal necrolysis of the epidermis. More common in neonates and children of age less than five years and are at a greater risk of SSSS. To fight against SSSS, children should attain lifetime immunity in the form of antibodies against exotoxins of staphylococcal strains. Symptoms include fever and redness on the overall surface of skin. Within 24-48h, fluid-filled blisters appear on the body. We report a case of 2-year-old male child developed SSSS after intravenous administration of Cefotaxime.

Key words: Staphylococcal scalded skin syndrome, Immunity, Exotoxins, Cefotaxime, Exfoliative, Cephalosporins.




 

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.

DOI HISTORY

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs